Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 83 of 99

  1. TAMSU-13-24

    Lacuna Pharma Pty Ltd

    Benign prostatic hyperplasia (BPH)

    phase 1 other active

    1 trial

  2. TAS0612-101

    Taiho Pharma Netherlands B.V.

    Locally Advanced or Metastatic Solid Tumors

    phase 1 other active

    1 trial

  3. TBA-354

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    2 trials

  4. TBA-7371

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  5. TBAJ-587

    BRIGHT MINDS BIOSCIENCES INC.

    Tuberculosis

    phase 1 small molecule completed

    1 trial

  6. TBAJ-876

    BRIGHT MINDS BIOSCIENCES INC.

    Pulmonary Disease

    phase 1 small molecule completed

    1 trial

  7. TBP-PI-HBr

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  8. TBP-PI-HBr

    Spero Therapeutics

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  9. TBPM-PI-HBr

    Spero Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  10. TBio-6517

    Takeda

    Solid Tumor

    phase 1 mab terminated

    1 trial

  11. TCR-T cells

    The First People's Hospital of Lianyungang

    Recurrent Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  12. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  13. TD-0714

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  14. TD-1058

    Theravance Biopharma Ireland Umited

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 1 small molecule terminated

    1 trial

  15. TD-1211 Dose 1

    Theravance Biopharma Ireland Umited

    Constipation

    phase 1 small molecule completed

    1 trial

  16. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Adults, Elderly Subjects

    phase 1 small molecule completed

    1 trial

  17. TD-1439

    Theravance Biopharma Ireland Umited

    Healthy Subjects

    phase 1 small molecule completed

    1 trial

  18. TD-1473

    Theravance Biopharma Ireland Umited

    Ulcerative Colitis, Active Moderate

    phase 1 small molecule completed

    1 trial

  19. TD-1473

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Disease

    phase 1 small molecule completed

    1 trial

  20. TD-1473 - Dose A

    Theravance Biopharma Ireland Umited

    Inflammatory Bowel Diseases

    phase 1 small molecule completed

    1 trial

  21. TD-1473 [Tablet A]

    Theravance Biopharma Ireland Umited

    Intestinal Disorder

    phase 1 small molecule completed

    1 trial

  22. TD-1473 for SAD

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  23. TD-1473 oral capsule

    Theravance Biopharma Ireland Umited

    Intestinal Disorders

    phase 1 small molecule completed

    1 trial

  24. TD-1607

    Theravance Biopharma Ireland Umited

    Serious Infections Due to Known or Suspected Gram-positive Pathogens

    phase 1 small molecule completed

    1 trial

  25. TD-1607

    Theravance Biopharma Ireland Umited

    Infections

    phase 1 small molecule completed

    1 trial

  26. TD-3504

    Theravance Biopharma Ireland Umited

    Active Mild Ulcerative Colitis, Active Moderate Ulcerative Colitis, Healthy Subjects

    phase 1 small molecule completed

    1 trial

  27. TD-4208

    Theravance Biopharma Ireland Umited

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  28. TD-4208

    Theravance Biopharma Ireland Umited

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  29. TD-4208 175 mcg

    Theravance Biopharma Ireland Umited

    Cardiac Repolarization in Healthy Subjects

    phase 1 small molecule completed

    1 trial

  30. TD-5202

    Theravance Biopharma Ireland Umited

    Healthy

    phase 1 small molecule completed

    1 trial

  31. TD-6450

    Theravance Biopharma Ireland Umited

    Hepatitis C

    phase 1 small molecule completed

    2 trials

  32. TD-8954

    Theravance Biopharma Ireland Umited

    Gastrointestinal Motility Disorder

    phase 1 small molecule terminated

    1 trial

  33. TD-9855

    Theravance Biopharma Ireland Umited

    Drug Drug Interaction (DDI)

    phase 1 small molecule completed

    1 trial

  34. TD-9855

    Theravance Biopharma Ireland Umited

    ADHD

    phase 1 small molecule completed

    1 trial

  35. TDV - Low Dose

    Takeda

    Dengue Fever

    phase 1 mab completed

    1 trial

  36. TED18162

    Sanofi-aventis Healthcare Pty Ltd

    Plasma cell myeloma refractory

    phase 1 other active

    1 trial

  37. TETRALITE-Ib

    Teva Pharma GmbH

    Influenza

    phase 1 other active

    1 trial

  38. TEV-48125 - 1

    Teva Pharma GmbH

    Pharmacokinetics

    phase 1 small molecule completed

    1 trial

  39. TEV-53408

    Teva Pharma GmbH

    Vitiligo

    phase 1 small molecule active

    1 trial

  40. TEV-56278

    Teva Pharma GmbH

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  41. TEV-56286

    Teva Pharma GmbH

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  42. TEV-56286 Test

    Teva Pharma GmbH

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  43. TG-0054

    Structure Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial

  44. TG-1701

    TG THERAPEUTICS, INC.

    Non Hodgkin Lymphoma

    phase 1 small molecule terminated

    1 trial

  45. TG-1801

    TG THERAPEUTICS, INC.

    CLL

    phase 1 mab terminated

    1 trial

  46. TG-1801

    TG THERAPEUTICS, INC.

    B-Cell Lymphoma

    phase 1 small molecule completed

    1 trial

  47. TG1101-RMS-SC101

    TG THERAPEUTICS, INC.

    Relapsing multiple sclerosis, Myasthenia Gravis

    phase 1 small molecule active

    1 trial

  48. TGD001 SAD study in healthy volunteers

    Lacuna Pharma Pty Ltd

    A Phase I randomized, double-blind, placebo-controlled study to assess the safety and pharmacokinetics of single-ascending doses of TGD001 in healthy volunteers

    phase 1 other active

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.